Literature DB >> 11144957

Technique for bilateral intracranial implantation of cells in monkeys using an automated delivery system.

K S Bankiewicz1, J Bringas, P Pivirotto, E Kutzscher, D Nagy, M E Emborg.   

Abstract

Intracerebral grafting combined with gene transfer may provide a powerful technique for local delivery of therapeutic agents into the CNS. The present study was undertaken to: (i) develop a reliable and reproducible automated cell implantation system, (ii) determine optimal implantation parameters of cells into the striatum, (iii) determine upper safe limits of cellular implantation into the neostriatum of monkeys. Autologous fibroblasts were infused into six sites of the striatum in nonhuman primates (Macaca mulatta, n = 11). Twenty-six-gauge cannulae were inserted vertically through cortical entry sites into the striatum (two sites in the caudate nucleus and four sites in the putamen) at predefined coordinates based on magnetic resonance imaging (MRI). The cannulae were guided by an electronically operated, hydraulic micropositioner and withdrawn at controlled rates, while cells (5, 10, 20, 40, or 80 microl/site) were infused simultaneously. Varying infusion rates and cell concentrations were also evaluated. Visualization and evaluation of graft placement were performed using contrast MRI at 3-5 days postsurgery. Animals were monitored for signs of clinical complications and sacrificed 2 weeks following surgery. Postimplantation MRI revealed a tissue mass effect of the implant with shifting of midline, edema, and infiltration of the white tracts at 40 and 80 microl/site. In addition, these animals developed transient hemiparesis contralateral to the implant site. MRI of animals grafted with 20 microl/site exhibited columnar-shaped implants and evidence of infiltration into white matter tracts possibly due to a volume effect. No clinical side effects were seen in this group. At 14 days postsurgery, MRI scans showed consistent columnar grafts (measuring approximately 5 mm in height) throughout the striatum in animals implanted with 5 or 10 microl/site. No signs of clinical side effects were associated with these volumes and postmortem histological examination confirmed MRI observations. Optimal surgical parameters for delivery of cells into the striatum consist of a graft volume of 10 microl/site, an infusion rate of 1.6 microl/min, a cell concentration of 2.0 x 10(5) cells/microl, and a cannula withdrawal rate of 0.75 mm/min. These results show that infusion of cells into the striatum can be done in a safe and routine manner.

Entities:  

Mesh:

Year:  2000        PMID: 11144957     DOI: 10.1177/096368970000900505

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  8 in total

1.  Real-Time Intraoperative MRI Intracerebral Delivery of Induced Pluripotent Stem Cell-Derived Neurons.

Authors:  Scott C Vermilyea; Jianfeng Lu; Miles Olsen; Scott Guthrie; Yunlong Tao; Eva M Fekete; Marissa K Riedel; Kevin Brunner; Carissa Boettcher; Viktorya Bondarenko; Ethan Brodsky; Walter F Block; Andrew Alexander; Su-Chun Zhang; Marina E Emborg
Journal:  Cell Transplant       Date:  2016-09-14       Impact factor: 4.064

2.  Intraoperative intracerebral MRI-guided navigation for accurate targeting in nonhuman primates.

Authors:  Marina E Emborg; Valerie Joers; Ronald Fisher; Kevin Brunner; Victoria Carter; Chris Ross; Raghu Raghavan; Martin Brady; James Raschke; Ken Kubota; Andrew Alexander
Journal:  Cell Transplant       Date:  2010-06-29       Impact factor: 4.064

3.  Interventional magnetic resonance imaging-guided cell transplantation into the brain with radially branched deployment.

Authors:  Matthew T Silvestrini; Dali Yin; Alastair J Martin; Valerie G Coppes; Preeti Mann; Paul S Larson; Philip A Starr; Xianmin Zeng; Nalin Gupta; S S Panter; Tejal A Desai; Daniel A Lim
Journal:  Mol Ther       Date:  2014-08-20       Impact factor: 11.454

4.  Radially branched deployment for more efficient cell transplantation at the scale of the human brain.

Authors:  Matthew T Silvestrini; Dali Yin; Valerie G Coppes; Preeti Mann; Alastair J Martin; Paul S Larson; Philip A Starr; Nalin Gupta; S Scott Panter; Tejal A Desai; Daniel A Lim
Journal:  Stereotact Funct Neurosurg       Date:  2013-01-22       Impact factor: 1.875

Review 5.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

6.  MRI-guided dissection of the nonhuman primate brain: a case study.

Authors:  James Bernard Daunais; Robert Arthur Kraft; April Teresa Davenport; Elizabeth J Burnett; Vicki Moser Maxey; Kendall Thomas Szeliga; Andrew Ryan Rau; Graham Stallard Flory; Scott Edwards Hemby; Christopher David Kroenke; Kathleen Alice Grant; David Paul Friedman
Journal:  Methods       Date:  2009-04-11       Impact factor: 3.608

Review 7.  The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.

Authors:  Scott C Vermilyea; Marina E Emborg
Journal:  J Neural Transm (Vienna)       Date:  2017-03-22       Impact factor: 3.575

Review 8.  Gene-based therapy of Parkinson's Disease: Translation from animal model to human clinical trial employing convection enhanced delivery.

Authors:  Gurwattan S Miranpuri; Lauren Kumbier; Angelica Hinchman; Dominic Schomberg; Anyi Wang; Hope Marshall; Ken Kubota; Chris Ross; Karl Sillay
Journal:  Ann Neurosci       Date:  2012-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.